Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFlexion Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Flexion Therapeutics, Inc. Earnings Date And Information
Flexion Therapeutics, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 21.33 M for the quarter and had revenue of 85.55 M for the year. Flexion Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.66 diluted earnings per share) and currently has a price-to-earnings ratio of -9.78. Flexion Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 12th, 2021 based on prior year's report dates.
Flexion Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2021 | Q3 2021 | N/A | -$0.60 | N/A | N/A | $21.33 M |
| 08/04/2021 | Q2 2021 | N/A | -$0.44 | N/A | N/A | $28.18 M |
| 05/12/2021 | Q1 2021 | N/A | -$0.57 | N/A | N/A | $24.59 M |
| 03/10/2021 | Q4 2020 | N/A | -$0.46 | N/A | N/A | $26.31 M |
| 11/04/2020 | Q3 2020 | N/A | -$0.00 | N/A | N/A | $23.66 M |
| 08/05/2020 | Q2 2020 | N/A | -$0.76 | N/A | N/A | $15.45 M |
| 05/07/2020 | Q1 2020 | N/A | -$0.95 | N/A | N/A | $20.13 M |
| 03/12/2020 | Q4 2019 | N/A | -$0.87 | N/A | N/A | $23.65 M |
| 11/07/2019 | Q3 2019 | N/A | -$1.00 | N/A | N/A | $21.79 M |
| 08/06/2019 | Q2 2019 | N/A | -$0.96 | N/A | N/A | $16.95 M |
| 05/08/2019 | Q1 2019 | N/A | -$1.09 | N/A | N/A | $10.56 M |
| 02/28/2019 | Q4 2018 | N/A | -$1.07 | N/A | N/A | $9.54 M |
| 11/07/2018 | Q3 2018 | N/A | -$1.15 | N/A | N/A | $6.99 M |
| 08/07/2018 | Q2 2018 | N/A | -$1.16 | N/A | N/A | $3.80 M |
| 05/08/2018 | Q1 2018 | N/A | -$1.10 | N/A | N/A | $2.19 M |
| 03/08/2018 | Q4 2017 | N/A | -$1.34 | N/A | N/A | $355.00 K |
| 11/06/2017 | Q3 2017 | N/A | -$1.07 | N/A | N/A | $0 |
| 08/08/2017 | Q2 2017 | N/A | -$0.91 | N/A | N/A | $0 |
| 05/05/2017 | Q1 2017 | N/A | -$0.75 | N/A | N/A | $0 |
| 03/10/2017 | Q4 2016 | N/A | -$0.73 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Flexion Therapeutics, Inc. Earnings: FAQ's
Flexion Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 12th, 2021 based offlast year's report dates.
The conference call for Flexion Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Flexion Therapeutics, Inc.'s latest earnings report can be read online.
Flexion Therapeutics, Inc. (:FLXN) has a recorded annual revenue of $85.55 M.
Flexion Therapeutics, Inc. (:FLXN) has a recorded net income of $-113,706,000.Flexion Therapeutics, Inc. has generated $-2.66 earnings per share over the last four quarters.
Flexion Therapeutics, Inc. (:FLXN) has a price-to-earnings ratio of -9.78 and price/earnings-to-growth ratio is -0.1.